105
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Microarray analysis to reveal genes involved in colon carcinogenesis

&
Pages 895-900 | Published online: 01 May 2007

Bibliography

  • HEGDE P, QI R, GASPARD R et al.: Identification of tumour markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. (2001) 61:7792-7797.
  • SEIDEN-LONG I M, BROWN K R, SHIH W et al.: Transcriptional targets of hepatocyte growth factor signalling and Ki-ras oncogene activaton in colorectal cancer. Oncogene (2006) 25:91-102.
  • ROBERTS ML, DROSOPOULOS G, VASILEIOU I et al.: Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line. Int. J. Cancer (2006) 118:616-627.
  • KOMATSU K, BUCHANAN F G, OTAKA M et al.: Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells. Molecular Cancer (2006) 5:63.
  • FUJIWARA K, OCHIAI M, OHTA T et al.: Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine. Carcinogenesis (2004) 25(8):1495-1505.
  • NISHIZUKA S, CHEN S, GWADRY FG et al.: Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic and tissue array profiling. Cancer Res. (2003) 63:5243-5250.
  • LIN Y, FURUKAWA Y, TSUNODA T, YUE C, YANG K, NAKAMURA Y: Molecular diagnosis of colorectal tumours by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene (2002) 21:4120-4128.
  • SAKAI M, SHIMOKAWA T, KOBAYASHI T et al.: Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene (2006) 25:480-486.
  • NOSHO K, YAMAMOTO H, ADACHI Y, ENDO T, HINODA Y, IMAI K: Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. Br. J. Cancer (2005) 92:1193-1200.
  • AGRAWAL D, CHEN T, IRBY R et al.: Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl Cancer Inst. (2002) 94(7):513-521.
  • AGRAWAL D, CHEN T, IRBY R et al.: Osteopontin identified as colon tumor progression marker. Molecular Biology and Genetics (2003) 326:1041-1043.
  • DI PIETRO M, BELLVER J S, MENIGATTI M et al.: Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology (2005) 129:1047-1059.
  • ESCHRICH S, YANG I, BLOOM G et al.: Molecular staging for survival prediction of colorectal cancer patients. J. Clin. Oncol. (2005) 23(15):3526-3535.
  • UCHIDA N, TSUNODA T, WADA S, FURUKAWA Y, NAKAMURA Y, TAHARA H: Ring finger protein 43 as a new target for cancer immunotherapy. Clinical Cancer Res. (2004) 10:8577-8586.
  • TOIYAMA Y, MIZOGUCHI A, KIMURA K et al.: Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J. Gastroenterol. (2005) 11(33):5151-5135.
  • TAKAHASHI M, LIN Y, NAKAMURA Y, FURUKAWA Y: Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer. Oncogene (2004) 23:9289-9294.
  • BARRIER A, LEMOINE A, BOELLE PY et al.: Colon cancer prognosis prediction by gene expression profiling. Oncogene (2005) 24:6155-6164.
  • BARRIER A, ROSER F, BOELLE P-Y et al.: Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol. (2006) 29:4685-4691.
  • BARRIER A, BOELLE P Y, ROSER F et al: Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol. (2006) 29:4685-4691.
  • WANG Y, JATKOE T, ZHANG Y et al.: Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J. Clin. Oncol. (2004) 22:1564-1571.
  • RESNICK M B, ROUTHIER J, KONKIN T, SABO E, PRICOLO VE: Epidermal growth factor receptor, c-met, β-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clinical Cancer Res. (2004) 10:3069-3075.
  • ZOU T, SELARU F, XU Y et al.: Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene (2002) 21:4855-4862.
  • BERTUCCI F, SALAS S, EYSTERIES S et al.: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene (2004) 23:1377-1391.
  • GIORDANO T J, SHEDDEN K A, SCHWARTZ D R et al.: Organ-specific molecular classification of primary lung, colon and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol. (2001) 159(4):1231-1238.
  • NOTTERMAN D A, ALON U, SIERK AJ, LEVINE A J: Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma and normal tissue examined by oligonucleotide arrays. Cancer Res. (2001) 61:3124-3130.
  • SOLMI R, UGOLINI G, ROSATI G et al.: Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. BMC Cancer (2006) 6:250.
  • BIBIKOVA M, YEAKLEY JM, CHUDIN E et al.: Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Clin. Chem. (2004) 50(12):2384-2386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.